| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +584K | 56.4% | $17.13 | +$10M |
| Sells | 6 | -451K | 43.6% | $17.51 | -$7.9M |
| Net | -5 | +132K | 12.8% | +$2.1M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Dennis D. Kim | Chief Medical Officer | $474K | Apr 13, 2023 | ||
| Charles McWherter | President of R&D | $0 | -$1.79M | -100% | Mar 22, 2024 |
| Robert James Wills | Director | $0 | Mar 22, 2024 | ||
| Paul Quinlan | General Counsel | $0 | -$1.34M | -100% | Mar 22, 2024 |
| Klara Dickinson | Chief Regulatory Officer | $0 | Mar 22, 2024 | ||
| Harish Shantharam | Chief Financial Officer | $0 | Mar 22, 2024 | ||
| Janet Dorling | Director | $0 | -$562K | -100% | Mar 22, 2024 |
| Sujal Shah | Chief Executive Officer, Director | $0 | -$3.25M | -100% | Mar 22, 2024 |
| Kurt Von Emster | Director | $0 | -$250K | -100% | Mar 22, 2024 |
| Daniel Menold | Vice President, Finance | -$708K | Jan 16, 2024 | ||
| Thomas G. Wiggans | Director | Mar 22, 2024 | |||
| Caroline M. Loewy | Director | Mar 22, 2024 | |||
| Lewis J. Stuart | Chief Commercial Officer | Jan 25, 2023 | |||
| Avoro Capital Advisors LLC | 10%+ Owner | +$10M | Sep 12, 2023 | ||
| Eric Lefebvre | Director | Mar 22, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|